Gliknik

Gliknik

Verified
Develops therapies for patients with cancer and immune disorders

Launch date
Employees
Ownership
Firm valuation
$75m (Dealroom.co estimates Jun 2021.)
Baltimore Maryland (HQ)
  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
N/A$2.9mSeries A
$2.4mEarly VC
$3.5mEarly VC
N/A$2mEarly VC
$4.9mSeries B
N/A$20mEarly VC
N/A$2.8mEarly VC
$15mEarly VC
$11.5m
Valuation: $75m
Series C
Total Funding$65m

Recent News about Gliknik

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.